1 Year Absolute Returns
-
NAV (₹) on 18 Dec 2025
9.60
1 Day NAV Change
0.15%
Risk Level
Very High Risk
Rating
-
Bajaj Finserv Healthcare Fund is a Equity mutual fund categorized under Sector, offered by Bajaj Finserv Asset Management Limited. Launched on 06 Dec 2024, investors can start with a lumpsum ... Read more
AUM
₹ 338.55 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 65.55% |
| Hospitals & Medical Services | 14.56% |
| Net Receivables/(Payables) | 4.50% |
| Personal Care | 2.95% |
| Food Processing & Packaging | 2.69% |
| Medical Research Services | 2.65% |
| Chemicals - Speciality | 2.57% |
| Plastics - Plastic & Plastic Products | 1.56% |
| Insurance Distributor | 1.35% |
| Edible Oils & Solvent Extraction | 1.18% |
| Financial Technologies (Fintech) | 0.44% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Divi's Laboratories Limited | 8.71% | ₹ 27.97 | Pharmaceuticals |
| Sun Pharmaceutical Industries Limited | 7.82% | ₹ 25.10 | Pharmaceuticals |
| Cipla Limited | 6.61% | ₹ 21.21 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 5.86% | ₹ 18.82 | Hospitals & Medical Services |
| Net Receivables / (Payables) | 4.50% | ₹ 14.50 | Others |
| Dr. Reddy's Laboratories Limited | 3.52% | ₹ 11.32 | Pharmaceuticals |
| Piramal Pharma Limited | 3.50% | ₹ 11.25 | Pharmaceuticals |
| Biocon Limited | 3.43% | ₹ 11 | Pharmaceuticals |
| Emcure Pharmaceuticals Limited | 3.40% | ₹ 10.91 | Pharmaceuticals |
| Glenmark Pharmaceuticals Limited | 2.81% | ₹ 9.03 | Pharmaceuticals |
| Neuland Laboratories Limited | 2.76% | ₹ 8.87 | Pharmaceuticals |
| Syngene International Limited | 2.65% | ₹ 8.50 | Medical Research Services |
| GlaxoSmithKline Pharmaceuticals Limited | 2.63% | ₹ 8.43 | Pharmaceuticals |
| Torrent Pharmaceuticals Limited | 2.42% | ₹ 7.77 | Pharmaceuticals |
| Abbott India Limited | 2.33% | ₹ 7.47 | Pharmaceuticals |
| Pfizer Limited | 2.24% | ₹ 7.21 | Pharmaceuticals |
| IPCA Laboratories Limited | 2.24% | ₹ 7.19 | Pharmaceuticals |
| Sanofi Consumer Healthcare India Limited | 2.08% | ₹ 6.67 | Chemicals - Speciality |
| Rainbow Childrens Medicare Limited | 2.01% | ₹ 6.44 | Hospitals & Medical Services |
| Zydus Wellness Limited | 1.94% | ₹ 6.22 | Food Processing & Packaging |
| Dr. Lal Path Labs Limited | 1.90% | ₹ 6.10 | Hospitals & Medical Services |
| Vijaya Diagnostic Centre Limited | 1.84% | ₹ 5.90 | Hospitals & Medical Services |
| Fortis Healthcare Limited | 1.72% | ₹ 5.51 | Hospitals & Medical Services |
| Hindustan Uever Limited | 1.58% | ₹ 5.09 | Personal Care |
| Shaily Engineering Plastics Limited | 1.56% | ₹ 5 | Plastics - Plastic & Plastic Products |
| Alkem Laboratories Limited | 1.52% | ₹ 4.87 | Pharmaceuticals |
| Orchid Pharma Limited | 1.38% | ₹ 4.44 | Pharmaceuticals |
| Emami Limited | 1.37% | ₹ 4.40 | Personal Care |
| Medi Assist Healthcare Services Limited | 1.35% | ₹ 4.32 | Insurance Distributor |
| MedPlus Health Services Limited | 1.34% | ₹ 4.29 | Pharmaceuticals |
| Jubilant Pharmova Limited | 1.28% | ₹ 4.11 | Pharmaceuticals |
| Alembic Pharmaceuticals Limited | 1.27% | ₹ 4.07 | Pharmaceuticals |
| Max Healthcare Institute Limited | 1.23% | ₹ 3.94 | Hospitals & Medical Services |
| Lupin Limited | 1.20% | ₹ 3.84 | Pharmaceuticals |
| Marico Limited | 1.18% | ₹ 3.80 | Edible Oils & Solvent Extraction |
| AstraZeneca Pharma India Limited | 1.13% | ₹ 3.62 | Pharmaceuticals |
| Mankind Pharma Limited | 1.12% | ₹ 3.58 | Pharmaceuticals |
| Aurobindo Pharma Limited | 0.89% | ₹ 2.87 | Pharmaceuticals |
| Nestle India Limited | 0.75% | ₹ 2.40 | Food Processing & Packaging |
| Neogen Chemicals Limited | 0.49% | ₹ 1.58 | Chemicals - Speciality |
| PB Fintech Limited | 0.44% | ₹ 1.41 | Financial Technologies (Fintech) |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 7.56% | - | - | - |
| Category returns | 12.61% | 0.69% | 15.54% | 26.16% |
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Bajaj Finserv Equity Savings Fund - Direct Plan
Hybrid
Direct
|
₹10.17 | 0.00% | 0.00% | 0.00% | ₹29 | 0.30% |
Moderate
|
|
Bajaj Finserv Liquid Fund
Liquid
Regular
|
₹1,034.31 | 0.01% | 0.00% | 0.00% | ₹6,206 | 0.28% |
Low to Moderate
|
|
Bajaj Finserv Money Market Fund
Liquid
Regular
|
₹1,179.78 | 6.91% | 0.00% | 0.00% | ₹6,065 | 0.76% |
Low to Moderate
|
|
Bajaj Finserv Overnight Fund
Liquid
Regular
|
₹1,033.35 | 0.02% | 0.00% | 0.00% | ₹552 | 0.12% |
Low
|
|
Bajaj Finserv Banking and PSU Fund - Direct Plan
Income
Direct
|
₹11.81 | 7.81% | 0.00% | 0.00% | ₹319 | 0.34% |
Moderate
|
|
Bajaj Finserv Money Market Fund
Liquid
Regular
|
₹1,179.78 | 6.91% | 0.00% | 0.00% | ₹6,065 | 0.76% |
Low to Moderate
|
|
Bajaj Finserv Nifty Bank ETF
ETF
Regular
|
₹59.67 | 13.72% | 0.00% | 0.00% | ₹373 | 0.13% |
Very High
|
|
Bajaj Finserv Liquid Fund - Direct Plan
Liquid
Direct
|
₹1,035.20 | 0.01% | 0.00% | 0.00% | ₹6,206 | 0.11% |
Low to Moderate
|
|
Bajaj Finserv Nifty 1D Rate Liquid ETF - Growth
ETF
Regular
|
₹1,000 | 0.00% | 0.00% | 0.00% | ₹657 | 0.19% |
Low
|
|
Bajaj Finserv Banking and PSU Fund - Direct Plan
Income
Direct
|
₹11.81 | 7.81% | 0.00% | 0.00% | ₹319 | 0.34% |
Moderate
|
What is the current NAV of Bajaj Finserv Healthcare Fund Regular IDCW-Reinvestment?
The current Net Asset Value (NAV) of Bajaj Finserv Healthcare Fund Regular IDCW-Reinvestment is ₹9.60 as of 18 Dec 2025. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Bajaj Finserv Healthcare Fund Regular IDCW-Reinvestment?
The Assets Under Management (AUM) of Bajaj Finserv Healthcare Fund Regular IDCW-Reinvestment is ₹338.55 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Bajaj Finserv Healthcare Fund Regular IDCW-Reinvestment?
Bajaj Finserv Healthcare Fund Regular IDCW-Reinvestment has delivered returns of 0.00% (1 Year), 0.00% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Bajaj Finserv Healthcare Fund Regular IDCW-Reinvestment?
Bajaj Finserv Healthcare Fund Regular IDCW-Reinvestment has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Bajaj Finserv Healthcare Fund Regular IDCW-Reinvestment?
The minimum lumpsum investment required for Bajaj Finserv Healthcare Fund Regular IDCW-Reinvestment is ₹500. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article